NCT00207129已完成1 期
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies
R-Pharm1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2004年10月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- Effect of capecitabine on the pharmacokinetics of BMS-247550 and to assess the effect of BMS-247550 on the pharmacokinetics of capecitabine
研究概览
简要总结
The purpose of this study is to test how BMS-247550 (ixabepilone) affects the removal of capecitabine from the body and how capecitabine affects the removal of BMS-247550 from the body.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Recovery from surgery or radiation therapy
- •Measurable or non-measurable disease
- •Available for follow-up
排除标准
- •Neuropathy
- •Uncontrolled pulmonary or cardiovascular disease
- •Known history of HIV infection
研究组 & 干预措施
A
Experimental
干预措施: Ixabepilone (Drug)
B
Experimental
干预措施: Capecitabine (Drug)
结局指标
主要结局
Effect of capecitabine on the pharmacokinetics of BMS-247550 and to assess the effect of BMS-247550 on the pharmacokinetics of capecitabine
次要结局
- Safety/Tumor response
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced CancerAdvanced Solid TumorsNeoplasmsNCT00207090R-Pharm19
终止
4 期
Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach AdenocarcinomaAdenocarcinoma of the StomachNCT00871273Cambridge University Hospitals NHS Foundation Trust13
尚未招募
不适用
A study of pharmacokinetic analysis of capecitabine and cytidine deaminase activityBreast and colorectal cancerJPRN-UMIN000019244Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital20
已完成
不适用
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body WeightNeoplasmsObesityNCT01828554University of Wisconsin, Madison8
已完成
2 期
BMS 247550 to Treat Kidney CancerRenal Cell CarcinomaNCT00030992National Cancer Institute (NCI)102